nodes	percent_of_prediction	percent_of_DWPC	metapath
Pregabalin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000174	CcSEcCtD
Pregabalin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000174	CcSEcCtD
Pregabalin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000174	CcSEcCtD
Pregabalin—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000173	0.000173	CcSEcCtD
Pregabalin—Myocardial infarction—Prednisone—systemic scleroderma	0.000173	0.000173	CcSEcCtD
Pregabalin—Breast disorder—Methotrexate—systemic scleroderma	0.000173	0.000173	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000173	0.000173	CcSEcCtD
Pregabalin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000173	CcSEcCtD
Pregabalin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000172	0.000172	CcSEcCtD
Pregabalin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000172	0.000172	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000172	CcSEcCtD
Pregabalin—Insomnia—Lisinopril—systemic scleroderma	0.000172	0.000172	CcSEcCtD
Pregabalin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000172	CcSEcCtD
Pregabalin—Paraesthesia—Lisinopril—systemic scleroderma	0.000171	0.000171	CcSEcCtD
Pregabalin—Vomiting—Captopril—systemic scleroderma	0.000171	0.000171	CcSEcCtD
Pregabalin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00017	0.00017	CcSEcCtD
Pregabalin—Dyspnoea—Lisinopril—systemic scleroderma	0.000169	0.000169	CcSEcCtD
Pregabalin—Rash—Captopril—systemic scleroderma	0.000169	0.000169	CcSEcCtD
Pregabalin—Dermatitis—Captopril—systemic scleroderma	0.000169	0.000169	CcSEcCtD
Pregabalin—Somnolence—Lisinopril—systemic scleroderma	0.000169	0.000169	CcSEcCtD
Pregabalin—Headache—Captopril—systemic scleroderma	0.000168	0.000168	CcSEcCtD
Pregabalin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000168	CcSEcCtD
Pregabalin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000167	0.000167	CcSEcCtD
Pregabalin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000167	0.000167	CcSEcCtD
Pregabalin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000166	CcSEcCtD
Pregabalin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000166	CcSEcCtD
Pregabalin—Asthma—Methotrexate—systemic scleroderma	0.000166	0.000166	CcSEcCtD
Pregabalin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000165	0.000165	CcSEcCtD
Pregabalin—Decreased appetite—Lisinopril—systemic scleroderma	0.000165	0.000165	CcSEcCtD
Pregabalin—Eosinophilia—Methotrexate—systemic scleroderma	0.000164	0.000164	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000164	0.000164	CcSEcCtD
Pregabalin—Fatigue—Lisinopril—systemic scleroderma	0.000164	0.000164	CcSEcCtD
Pregabalin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000164	0.000164	CcSEcCtD
Pregabalin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000163	0.000163	CcSEcCtD
Pregabalin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000163	0.000163	CcSEcCtD
Pregabalin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000163	0.000163	CcSEcCtD
Pregabalin—Pancreatitis—Methotrexate—systemic scleroderma	0.000163	0.000163	CcSEcCtD
Pregabalin—Constipation—Lisinopril—systemic scleroderma	0.000162	0.000162	CcSEcCtD
Pregabalin—Pain—Lisinopril—systemic scleroderma	0.000162	0.000162	CcSEcCtD
Pregabalin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000162	CcSEcCtD
Pregabalin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000162	CcSEcCtD
Pregabalin—Bradycardia—Prednisone—systemic scleroderma	0.000162	0.000162	CcSEcCtD
Pregabalin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000161	CcSEcCtD
Pregabalin—Diarrhoea—Azathioprine—systemic scleroderma	0.00016	0.00016	CcSEcCtD
Pregabalin—Haemoglobin—Prednisone—systemic scleroderma	0.00016	0.00016	CcSEcCtD
Pregabalin—Nausea—Captopril—systemic scleroderma	0.000159	0.000159	CcSEcCtD
Pregabalin—Haemorrhage—Prednisone—systemic scleroderma	0.000159	0.000159	CcSEcCtD
Pregabalin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000159	CcSEcCtD
Pregabalin—Asthenia—Leflunomide—systemic scleroderma	0.000159	0.000159	CcSEcCtD
Pregabalin—Hallucination—Prednisone—systemic scleroderma	0.000158	0.000158	CcSEcCtD
Pregabalin—Pancytopenia—Methotrexate—systemic scleroderma	0.000157	0.000157	CcSEcCtD
Pregabalin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000157	0.000157	CcSEcCtD
Pregabalin—Pruritus—Leflunomide—systemic scleroderma	0.000156	0.000156	CcSEcCtD
Pregabalin—Connective tissue disorder—Prednisone—systemic scleroderma	0.000156	0.000156	CcSEcCtD
Pregabalin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000156	CcSEcCtD
Pregabalin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000155	0.000155	CcSEcCtD
Pregabalin—Dysuria—Methotrexate—systemic scleroderma	0.000155	0.000155	CcSEcCtD
Pregabalin—Neutropenia—Methotrexate—systemic scleroderma	0.000155	0.000155	CcSEcCtD
Pregabalin—Dizziness—Azathioprine—systemic scleroderma	0.000155	0.000155	CcSEcCtD
Pregabalin—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000153	0.000153	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000152	CcSEcCtD
Pregabalin—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000151	0.000151	CcSEcCtD
Pregabalin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000151	0.000151	CcSEcCtD
Pregabalin—Diarrhoea—Leflunomide—systemic scleroderma	0.000151	0.000151	CcSEcCtD
Pregabalin—Urticaria—Lisinopril—systemic scleroderma	0.000151	0.000151	CcSEcCtD
Pregabalin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000151	CcSEcCtD
Pregabalin—Abdominal pain—Lisinopril—systemic scleroderma	0.00015	0.00015	CcSEcCtD
Pregabalin—Body temperature increased—Lisinopril—systemic scleroderma	0.00015	0.00015	CcSEcCtD
Pregabalin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000149	CcSEcCtD
Pregabalin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000149	0.000149	CcSEcCtD
Pregabalin—Vomiting—Azathioprine—systemic scleroderma	0.000149	0.000149	CcSEcCtD
Pregabalin—Pneumonia—Methotrexate—systemic scleroderma	0.000149	0.000149	CcSEcCtD
Pregabalin—Eye disorder—Prednisone—systemic scleroderma	0.000148	0.000148	CcSEcCtD
Pregabalin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000148	CcSEcCtD
Pregabalin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000148	CcSEcCtD
Pregabalin—Infestation—Methotrexate—systemic scleroderma	0.000148	0.000148	CcSEcCtD
Pregabalin—Infestation NOS—Methotrexate—systemic scleroderma	0.000148	0.000148	CcSEcCtD
Pregabalin—Rash—Azathioprine—systemic scleroderma	0.000148	0.000148	CcSEcCtD
Pregabalin—Dermatitis—Azathioprine—systemic scleroderma	0.000147	0.000147	CcSEcCtD
Pregabalin—Depression—Methotrexate—systemic scleroderma	0.000147	0.000147	CcSEcCtD
Pregabalin—Flushing—Prednisone—systemic scleroderma	0.000147	0.000147	CcSEcCtD
Pregabalin—Headache—Azathioprine—systemic scleroderma	0.000147	0.000147	CcSEcCtD
Pregabalin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000147	0.000147	CcSEcCtD
Pregabalin—Dizziness—Leflunomide—systemic scleroderma	0.000146	0.000146	CcSEcCtD
Pregabalin—Renal failure—Methotrexate—systemic scleroderma	0.000145	0.000145	CcSEcCtD
Pregabalin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000145	0.000145	CcSEcCtD
Pregabalin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000144	0.000144	CcSEcCtD
Pregabalin—Stomatitis—Methotrexate—systemic scleroderma	0.000144	0.000144	CcSEcCtD
Pregabalin—Angiopathy—Prednisone—systemic scleroderma	0.000144	0.000144	CcSEcCtD
Pregabalin—Conjunctivitis—Methotrexate—systemic scleroderma	0.000144	0.000144	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000144	CcSEcCtD
Pregabalin—Immune system disorder—Prednisone—systemic scleroderma	0.000143	0.000143	CcSEcCtD
Pregabalin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000142	CcSEcCtD
Pregabalin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000142	CcSEcCtD
Pregabalin—Arrhythmia—Prednisone—systemic scleroderma	0.000142	0.000142	CcSEcCtD
Pregabalin—Sweating—Methotrexate—systemic scleroderma	0.000142	0.000142	CcSEcCtD
Pregabalin—Haematuria—Methotrexate—systemic scleroderma	0.000141	0.000141	CcSEcCtD
Pregabalin—Vomiting—Leflunomide—systemic scleroderma	0.000141	0.000141	CcSEcCtD
Pregabalin—Alopecia—Prednisone—systemic scleroderma	0.00014	0.00014	CcSEcCtD
Pregabalin—Hypersensitivity—Lisinopril—systemic scleroderma	0.00014	0.00014	CcSEcCtD
Pregabalin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000139	0.000139	CcSEcCtD
Pregabalin—Epistaxis—Methotrexate—systemic scleroderma	0.000139	0.000139	CcSEcCtD
Pregabalin—Rash—Leflunomide—systemic scleroderma	0.000139	0.000139	CcSEcCtD
Pregabalin—Dermatitis—Leflunomide—systemic scleroderma	0.000139	0.000139	CcSEcCtD
Pregabalin—Mental disorder—Prednisone—systemic scleroderma	0.000139	0.000139	CcSEcCtD
Pregabalin—Nausea—Azathioprine—systemic scleroderma	0.000139	0.000139	CcSEcCtD
Pregabalin—Headache—Leflunomide—systemic scleroderma	0.000138	0.000138	CcSEcCtD
Pregabalin—Malnutrition—Prednisone—systemic scleroderma	0.000138	0.000138	CcSEcCtD
Pregabalin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000137	0.000137	CcSEcCtD
Pregabalin—Asthenia—Lisinopril—systemic scleroderma	0.000136	0.000136	CcSEcCtD
Pregabalin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000136	CcSEcCtD
Pregabalin—Pruritus—Lisinopril—systemic scleroderma	0.000134	0.000134	CcSEcCtD
Pregabalin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000134	0.000134	CcSEcCtD
Pregabalin—Haemoglobin—Methotrexate—systemic scleroderma	0.000133	0.000133	CcSEcCtD
Pregabalin—Rash—Mycophenolic acid—systemic scleroderma	0.000133	0.000133	CcSEcCtD
Pregabalin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000133	0.000133	CcSEcCtD
Pregabalin—Hepatitis—Methotrexate—systemic scleroderma	0.000133	0.000133	CcSEcCtD
Pregabalin—Haemorrhage—Methotrexate—systemic scleroderma	0.000133	0.000133	CcSEcCtD
Pregabalin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000132	CcSEcCtD
Pregabalin—Headache—Mycophenolic acid—systemic scleroderma	0.000132	0.000132	CcSEcCtD
Pregabalin—Pharyngitis—Methotrexate—systemic scleroderma	0.000132	0.000132	CcSEcCtD
Pregabalin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000132	CcSEcCtD
Pregabalin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000132	CcSEcCtD
Pregabalin—Nausea—Leflunomide—systemic scleroderma	0.000131	0.000131	CcSEcCtD
Pregabalin—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000131	0.000131	CcSEcCtD
Pregabalin—Vision blurred—Prednisone—systemic scleroderma	0.00013	0.00013	CcSEcCtD
Pregabalin—Urethral disorder—Methotrexate—systemic scleroderma	0.00013	0.00013	CcSEcCtD
Pregabalin—Diarrhoea—Lisinopril—systemic scleroderma	0.00013	0.00013	CcSEcCtD
Pregabalin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000128	0.000128	CcSEcCtD
Pregabalin—Visual impairment—Methotrexate—systemic scleroderma	0.000128	0.000128	CcSEcCtD
Pregabalin—Anaemia—Prednisone—systemic scleroderma	0.000128	0.000128	CcSEcCtD
Pregabalin—Agitation—Prednisone—systemic scleroderma	0.000127	0.000127	CcSEcCtD
Pregabalin—Angioedema—Prednisone—systemic scleroderma	0.000126	0.000126	CcSEcCtD
Pregabalin—Dizziness—Lisinopril—systemic scleroderma	0.000126	0.000126	CcSEcCtD
Pregabalin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000125	0.000125	CcSEcCtD
Pregabalin—Nausea—Mycophenolic acid—systemic scleroderma	0.000125	0.000125	CcSEcCtD
Pregabalin—Malaise—Prednisone—systemic scleroderma	0.000125	0.000125	CcSEcCtD
Pregabalin—Vertigo—Prednisone—systemic scleroderma	0.000124	0.000124	CcSEcCtD
Pregabalin—Eye disorder—Methotrexate—systemic scleroderma	0.000124	0.000124	CcSEcCtD
Pregabalin—Syncope—Prednisone—systemic scleroderma	0.000124	0.000124	CcSEcCtD
Pregabalin—Tinnitus—Methotrexate—systemic scleroderma	0.000124	0.000124	CcSEcCtD
Pregabalin—Cardiac disorder—Methotrexate—systemic scleroderma	0.000123	0.000123	CcSEcCtD
Pregabalin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000123	CcSEcCtD
Pregabalin—Loss of consciousness—Prednisone—systemic scleroderma	0.000121	0.000121	CcSEcCtD
Pregabalin—Vomiting—Lisinopril—systemic scleroderma	0.000121	0.000121	CcSEcCtD
Pregabalin—Angiopathy—Methotrexate—systemic scleroderma	0.00012	0.00012	CcSEcCtD
Pregabalin—Immune system disorder—Methotrexate—systemic scleroderma	0.00012	0.00012	CcSEcCtD
Pregabalin—Rash—Lisinopril—systemic scleroderma	0.00012	0.00012	CcSEcCtD
Pregabalin—Convulsion—Prednisone—systemic scleroderma	0.00012	0.00012	CcSEcCtD
Pregabalin—Dermatitis—Lisinopril—systemic scleroderma	0.00012	0.00012	CcSEcCtD
Pregabalin—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00012	0.00012	CcSEcCtD
Pregabalin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000119	CcSEcCtD
Pregabalin—Hypertension—Prednisone—systemic scleroderma	0.000119	0.000119	CcSEcCtD
Pregabalin—Chills—Methotrexate—systemic scleroderma	0.000119	0.000119	CcSEcCtD
Pregabalin—Headache—Lisinopril—systemic scleroderma	0.000119	0.000119	CcSEcCtD
Pregabalin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000118	0.000118	CcSEcCtD
Pregabalin—Myalgia—Prednisone—systemic scleroderma	0.000118	0.000118	CcSEcCtD
Pregabalin—Arthralgia—Prednisone—systemic scleroderma	0.000118	0.000118	CcSEcCtD
Pregabalin—Anxiety—Prednisone—systemic scleroderma	0.000117	0.000117	CcSEcCtD
Pregabalin—Alopecia—Methotrexate—systemic scleroderma	0.000117	0.000117	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000117	0.000117	CcSEcCtD
Pregabalin—Discomfort—Prednisone—systemic scleroderma	0.000116	0.000116	CcSEcCtD
Pregabalin—Mental disorder—Methotrexate—systemic scleroderma	0.000116	0.000116	CcSEcCtD
Pregabalin—Malnutrition—Methotrexate—systemic scleroderma	0.000116	0.000116	CcSEcCtD
Pregabalin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000114	CcSEcCtD
Pregabalin—Dysgeusia—Methotrexate—systemic scleroderma	0.000113	0.000113	CcSEcCtD
Pregabalin—Nausea—Lisinopril—systemic scleroderma	0.000113	0.000113	CcSEcCtD
Pregabalin—Oedema—Prednisone—systemic scleroderma	0.000113	0.000113	CcSEcCtD
Pregabalin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000113	0.000113	CcSEcCtD
Pregabalin—Infection—Prednisone—systemic scleroderma	0.000112	0.000112	CcSEcCtD
Pregabalin—Back pain—Methotrexate—systemic scleroderma	0.000112	0.000112	CcSEcCtD
Pregabalin—Shock—Prednisone—systemic scleroderma	0.000111	0.000111	CcSEcCtD
Pregabalin—Nervous system disorder—Prednisone—systemic scleroderma	0.000111	0.000111	CcSEcCtD
Pregabalin—Tachycardia—Prednisone—systemic scleroderma	0.00011	0.00011	CcSEcCtD
Pregabalin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00011	0.00011	CcSEcCtD
Pregabalin—Skin disorder—Prednisone—systemic scleroderma	0.00011	0.00011	CcSEcCtD
Pregabalin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000109	0.000109	CcSEcCtD
Pregabalin—Vision blurred—Methotrexate—systemic scleroderma	0.000109	0.000109	CcSEcCtD
Pregabalin—Anorexia—Prednisone—systemic scleroderma	0.000108	0.000108	CcSEcCtD
Pregabalin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000107	0.000107	CcSEcCtD
Pregabalin—Anaemia—Methotrexate—systemic scleroderma	0.000107	0.000107	CcSEcCtD
Pregabalin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000106	0.000106	CcSEcCtD
Pregabalin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000105	0.000105	CcSEcCtD
Pregabalin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000105	0.000105	CcSEcCtD
Pregabalin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000104	0.000104	CcSEcCtD
Pregabalin—Malaise—Methotrexate—systemic scleroderma	0.000104	0.000104	CcSEcCtD
Pregabalin—Vertigo—Methotrexate—systemic scleroderma	0.000104	0.000104	CcSEcCtD
Pregabalin—Leukopenia—Methotrexate—systemic scleroderma	0.000103	0.000103	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000103	0.000103	CcSEcCtD
Pregabalin—Insomnia—Prednisone—systemic scleroderma	0.000102	0.000102	CcSEcCtD
Pregabalin—Paraesthesia—Prednisone—systemic scleroderma	0.000101	0.000101	CcSEcCtD
Pregabalin—Cough—Methotrexate—systemic scleroderma	0.000101	0.000101	CcSEcCtD
Pregabalin—Convulsion—Methotrexate—systemic scleroderma	0.0001	0.0001	CcSEcCtD
Pregabalin—Nausea—Mycophenolate mofetil—systemic scleroderma	9.89e-05	9.89e-05	CcSEcCtD
Pregabalin—Myalgia—Methotrexate—systemic scleroderma	9.84e-05	9.84e-05	CcSEcCtD
Pregabalin—Chest pain—Methotrexate—systemic scleroderma	9.84e-05	9.84e-05	CcSEcCtD
Pregabalin—Arthralgia—Methotrexate—systemic scleroderma	9.84e-05	9.84e-05	CcSEcCtD
Pregabalin—Decreased appetite—Prednisone—systemic scleroderma	9.81e-05	9.81e-05	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	9.77e-05	9.77e-05	CcSEcCtD
Pregabalin—Fatigue—Prednisone—systemic scleroderma	9.73e-05	9.73e-05	CcSEcCtD
Pregabalin—Discomfort—Methotrexate—systemic scleroderma	9.72e-05	9.72e-05	CcSEcCtD
Pregabalin—Constipation—Prednisone—systemic scleroderma	9.65e-05	9.65e-05	CcSEcCtD
Pregabalin—Confusional state—Methotrexate—systemic scleroderma	9.51e-05	9.51e-05	CcSEcCtD
Pregabalin—Anaphylactic shock—Methotrexate—systemic scleroderma	9.43e-05	9.43e-05	CcSEcCtD
Pregabalin—Infection—Methotrexate—systemic scleroderma	9.37e-05	9.37e-05	CcSEcCtD
Pregabalin—Feeling abnormal—Prednisone—systemic scleroderma	9.3e-05	9.3e-05	CcSEcCtD
Pregabalin—Nervous system disorder—Methotrexate—systemic scleroderma	9.25e-05	9.25e-05	CcSEcCtD
Pregabalin—Thrombocytopenia—Methotrexate—systemic scleroderma	9.23e-05	9.23e-05	CcSEcCtD
Pregabalin—Gastrointestinal pain—Prednisone—systemic scleroderma	9.23e-05	9.23e-05	CcSEcCtD
Pregabalin—Skin disorder—Methotrexate—systemic scleroderma	9.16e-05	9.16e-05	CcSEcCtD
Pregabalin—Hyperhidrosis—Methotrexate—systemic scleroderma	9.11e-05	9.11e-05	CcSEcCtD
Pregabalin—Anorexia—Methotrexate—systemic scleroderma	8.99e-05	8.99e-05	CcSEcCtD
Pregabalin—Urticaria—Prednisone—systemic scleroderma	8.96e-05	8.96e-05	CcSEcCtD
Pregabalin—Abdominal pain—Prednisone—systemic scleroderma	8.92e-05	8.92e-05	CcSEcCtD
Pregabalin—Body temperature increased—Prednisone—systemic scleroderma	8.92e-05	8.92e-05	CcSEcCtD
Pregabalin—Hypotension—Methotrexate—systemic scleroderma	8.81e-05	8.81e-05	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	8.59e-05	8.59e-05	CcSEcCtD
Pregabalin—Insomnia—Methotrexate—systemic scleroderma	8.53e-05	8.53e-05	CcSEcCtD
Pregabalin—Paraesthesia—Methotrexate—systemic scleroderma	8.47e-05	8.47e-05	CcSEcCtD
Pregabalin—Dyspnoea—Methotrexate—systemic scleroderma	8.41e-05	8.41e-05	CcSEcCtD
Pregabalin—Somnolence—Methotrexate—systemic scleroderma	8.38e-05	8.38e-05	CcSEcCtD
Pregabalin—Hypersensitivity—Prednisone—systemic scleroderma	8.31e-05	8.31e-05	CcSEcCtD
Pregabalin—Decreased appetite—Methotrexate—systemic scleroderma	8.2e-05	8.2e-05	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	8.14e-05	8.14e-05	CcSEcCtD
Pregabalin—Fatigue—Methotrexate—systemic scleroderma	8.13e-05	8.13e-05	CcSEcCtD
Pregabalin—Asthenia—Prednisone—systemic scleroderma	8.09e-05	8.09e-05	CcSEcCtD
Pregabalin—Pain—Methotrexate—systemic scleroderma	8.06e-05	8.06e-05	CcSEcCtD
Pregabalin—Pruritus—Prednisone—systemic scleroderma	7.98e-05	7.98e-05	CcSEcCtD
Pregabalin—Feeling abnormal—Methotrexate—systemic scleroderma	7.77e-05	7.77e-05	CcSEcCtD
Pregabalin—Diarrhoea—Prednisone—systemic scleroderma	7.72e-05	7.72e-05	CcSEcCtD
Pregabalin—Gastrointestinal pain—Methotrexate—systemic scleroderma	7.71e-05	7.71e-05	CcSEcCtD
Pregabalin—Urticaria—Methotrexate—systemic scleroderma	7.49e-05	7.49e-05	CcSEcCtD
Pregabalin—Dizziness—Prednisone—systemic scleroderma	7.46e-05	7.46e-05	CcSEcCtD
Pregabalin—Abdominal pain—Methotrexate—systemic scleroderma	7.45e-05	7.45e-05	CcSEcCtD
Pregabalin—Body temperature increased—Methotrexate—systemic scleroderma	7.45e-05	7.45e-05	CcSEcCtD
Pregabalin—Vomiting—Prednisone—systemic scleroderma	7.17e-05	7.17e-05	CcSEcCtD
Pregabalin—Rash—Prednisone—systemic scleroderma	7.11e-05	7.11e-05	CcSEcCtD
Pregabalin—Dermatitis—Prednisone—systemic scleroderma	7.11e-05	7.11e-05	CcSEcCtD
Pregabalin—Headache—Prednisone—systemic scleroderma	7.07e-05	7.07e-05	CcSEcCtD
Pregabalin—Hypersensitivity—Methotrexate—systemic scleroderma	6.95e-05	6.95e-05	CcSEcCtD
Pregabalin—Asthenia—Methotrexate—systemic scleroderma	6.76e-05	6.76e-05	CcSEcCtD
Pregabalin—Nausea—Prednisone—systemic scleroderma	6.7e-05	6.7e-05	CcSEcCtD
Pregabalin—Pruritus—Methotrexate—systemic scleroderma	6.67e-05	6.67e-05	CcSEcCtD
Pregabalin—Diarrhoea—Methotrexate—systemic scleroderma	6.45e-05	6.45e-05	CcSEcCtD
Pregabalin—Dizziness—Methotrexate—systemic scleroderma	6.23e-05	6.23e-05	CcSEcCtD
Pregabalin—Vomiting—Methotrexate—systemic scleroderma	5.99e-05	5.99e-05	CcSEcCtD
Pregabalin—Rash—Methotrexate—systemic scleroderma	5.94e-05	5.94e-05	CcSEcCtD
Pregabalin—Dermatitis—Methotrexate—systemic scleroderma	5.94e-05	5.94e-05	CcSEcCtD
Pregabalin—Headache—Methotrexate—systemic scleroderma	5.91e-05	5.91e-05	CcSEcCtD
Pregabalin—Nausea—Methotrexate—systemic scleroderma	5.6e-05	5.6e-05	CcSEcCtD
